Literature DB >> 2476450

Fibronectin and fibrinolysis are not required for fibrin gel contraction by human skin fibroblasts.

T L Tuan1, F Grinnell.   

Abstract

Human skin fibroblasts contracted fibrin gels in a time- and cell-dependent manner. Under optimal conditions, gel contraction amounted to more than 50% in 2 hr. Fibronectin did not promote contraction, and fibrinolysis was not required for contraction, although gels contracted without serum or aprotinin were lysed. Before contraction, fibrin was present in loosely packed, randomly organized fibrils. After contraction, the fibrils were more densely packed and aligned in the plane of cell spreading. Cycloheximide treatment of fibroblasts inhibited gel contraction in serum-free medium but not in serum-containing medium. Fibronectin could not substitute for serum in overcoming the cycloheximide effect. Binding sites for fibrin were distributed randomly over the cells' surfaces based on electron microscopic observations. Often small groups of fibrils were localized in indentations at the cell surface. Finally, peptides containing the arg-gly-asp-ser sequence inhibited gel contraction.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2476450     DOI: 10.1002/jcp.1041400324

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  12 in total

1.  Hypoxic culture and insulin yield improvements to fibrin-based engineered tissue.

Authors:  Jason W Bjork; Lee A Meier; Sandra L Johnson; Zeeshan H Syedain; Robert T Tranquillo
Journal:  Tissue Eng Part A       Date:  2011-12-05       Impact factor: 3.845

2.  PDGF signaling is required for epicardial function and blood vessel formation in regenerating zebrafish hearts.

Authors:  Jieun Kim; Qiong Wu; Yolanda Zhang; Katie M Wiens; Ying Huang; Nicole Rubin; Hiroyuki Shimada; Robert I Handin; Michael Y Chao; Tai-Lan Tuan; Vaughn A Starnes; Ching-Ling Lien
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-21       Impact factor: 11.205

3.  Cells actively stiffen fibrin networks by generating contractile stress.

Authors:  Karin A Jansen; Rommel G Bacabac; Izabela K Piechocka; Gijsje H Koenderink
Journal:  Biophys J       Date:  2013-11-19       Impact factor: 4.033

Review 4.  Extracellular matrix as a driver for lung regeneration.

Authors:  Jenna L Balestrini; Laura E Niklason
Journal:  Ann Biomed Eng       Date:  2014-10-25       Impact factor: 3.934

5.  Increased plasminogen activator inhibitor-1 in keloid fibroblasts may account for their elevated collagen accumulation in fibrin gel cultures.

Authors:  Tai-Lan Tuan; Huayang Wu; Eunice Y Huang; Sheree S N Chong; Walter Laug; Diana Messadi; Paul Kelly; Anh Le
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

6.  Fibrin-induced skin fibrosis in mice deficient in tissue plasminogen activator.

Authors:  Alexander de Giorgio-Miller; Steve Bottoms; Geoffrey Laurent; Peter Carmeliet; Sarah Herrick
Journal:  Am J Pathol       Date:  2005-09       Impact factor: 4.307

7.  Controlled compaction with ruthenium-catalyzed photochemical cross-linking of fibrin-based engineered connective tissue.

Authors:  Zeeshan H Syedain; Jason Bjork; Lillian Sando; Robert T Tranquillo
Journal:  Biomaterials       Date:  2009-09-25       Impact factor: 12.479

8.  Adenoviral overexpression and small interfering RNA suppression demonstrate that plasminogen activator inhibitor-1 produces elevated collagen accumulation in normal and keloid fibroblasts.

Authors:  Tai-Lan Tuan; Paul Hwu; Wendy Ho; Peter Yiu; Richard Chang; Annette Wysocki; Paul D Benya
Journal:  Am J Pathol       Date:  2008-10-02       Impact factor: 4.307

9.  Fibroblast migration in fibrin gel matrices.

Authors:  L F Brown; N Lanir; J McDonagh; K Tognazzi; A M Dvorak; H F Dvorak
Journal:  Am J Pathol       Date:  1993-01       Impact factor: 4.307

10.  Fibrinogen inhibits fibroblast-mediated contraction of collagen.

Authors:  Yih-Dar Nien; Yuan-Ping Han; Bill Tawil; Linda S Chan; Tai-Lan Tuan; Warren L Garner
Journal:  Wound Repair Regen       Date:  2003 Sep-Oct       Impact factor: 3.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.